| 注册
首页|期刊导航|中医研究|活血解毒类中药调控核因子κB抗动脉粥样硬化机制的研究进展

活血解毒类中药调控核因子κB抗动脉粥样硬化机制的研究进展

师文琪 何鑫 刘国飞 司春婴 陈恒

中医研究2026,Vol.39Issue(8):86-91,6.
✕
中医研究2026,Vol.39Issue(8):86-91,6.DOI:10.3969/j.issn.1001-6910.2026.08.19

活血解毒类中药调控核因子κB抗动脉粥样硬化机制的研究进展

Research Progress on the Anti-atherosclerosis Mechanisms of Blood-activating and Detoxifying Traditional Chinese Medicines by Regulating NF-κB Pathway

师文琪 1何鑫 1刘国飞 1司春婴 2陈恒2

作者信息

  • 1. 河南中医药大学第一临床医学院(中西医结合学院),河南 郑州 450000
  • 2. 河南中医药大学第一附属医院,河南 郑州 450000
  • 折叠

摘要

Abstract

The nuclear factor κB(NF-κB)signaling pathway delays the occurrence and development of atherosclerosis(AS)by mediating endothelial cell injury,regulating macrophage polarization,ferroptosis,and regulating the stability of vascular smooth muscle cells and plaques.According to Traditional Chinese Medicine theories,blood stasis and toxins are mutually causal and interdependent factors,running through the occurrence and the entire process of AS.Based on the etiology and pathogenesis of AS,the method of promoting blood circulation and detoxification has become one of the important therapeutic approaches for AS.This paper systematically reviews the research progress on the active ingredients and compound prescriptions of blood-activating and detoxifying Traditional Chinese Medicines against AS by regulating NF-κB signaling pathway.It is suggested that the NF-κB pathway may be the key target of blood-activating and detoxifying Traditional Chinese Medicines for the prevention and treatment of AS.

关键词

动脉粥样硬化/NF-κB信号通路/病机病机/中药/活血解毒/作用机制

Key words

atherosclerosis/NF-κB signaling pathway/etiology and pathogenesis/Traditional Chinese Medicine/promotion of blood circulation and detoxication/mechanism

分类

医药卫生

引用本文复制引用

师文琪,何鑫,刘国飞,司春婴,陈恒..活血解毒类中药调控核因子κB抗动脉粥样硬化机制的研究进展[J].中医研究,2026,39(8):86-91,6.

基金项目

河南省医学科技攻关计划联合共建项目(LHGJ20240669) (LHGJ20240669)

河南省卫生健康委员会国家中医药传承创新中心联合共建科研专项课题(2024ZXZX1067) (2024ZXZX1067)

2023 年河南省本科高校大学生创新创业训练计划省级立项项目(202310471019) (202310471019)

中医研究

1001-6910

访问量0
|
下载量0
段落导航相关论文